Caitong International Asset Management Co., LTD Capricor Therapeutics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 123 shares of CAPR stock, worth $1,981. This represents 0.0% of its overall portfolio holdings.
Number of Shares
123
Previous 123
-0.0%
Holding current value
$1,981
Previous $1.7 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CAPR
# of Institutions
133Shares Held
16MCall Options Held
1.73MPut Options Held
1.71M-
Vanguard Group Inc Valley Forge, PA2.28MShares$36.7 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.25MShares$36.3 Million0.17% of portfolio
-
State Street Corp Boston, MA2.21MShares$35.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$26.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA879KShares$14.2 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $392M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...